|
Demand for high performance drugs and efficiency incentives are driving the pharma industry to
outsource an increasingly large share of their API production, whether it is for generic or innovative
APIs. The newest generation of APIs being developed are extremely complex; these include
peptides, high potency APIs, oligonucleotides, and sterile APIs. This means that the R&D and
certification processes themselves have also become longer and more complicated
In addition, a range of new technologies guided by gene shuffling, catalytic, fermentation, enzymatic
and bio transformation platforms, have opened up new vistas for the industry to explore.
Chiral
India 2020 brings to you under the broad theme "New
pharmaceutical technologies: Shaping the future of drug development"
a range of novel chemistry and technology advances poised to shape
the future of the pharmaceuticals industry.
Agenda
|
December
2
Chral Drug
Design And Development |
December
3
Advances In
Drug Synthesis |
December
4
New Technology
Directions |
|
- Advances
in Chiral catalysis
|
- The
Power of Oxidative Iodine Catalysis
|
- Chiral
synthesis of agrochemicals
|
|
- New
developments in organocatalysis for asymmetric synthesis
|
- Advances
in carbohydrate chemistry for new drug development
|
- Advances
in formulation technologies
|
|
- Enantioselective
Domino Reactions of Diazo Compounds Catalyzed by COBI
|
- Commercial
utility of cross coupling reactions in drug development
|
- Recent
trends and challenges of Biocatalytic processes in the Pharma
Industry
|
|
|
|
|
|
|
|
